3.0.0
3093
2024-07-24T15:22:19Z
2024-07-24T15:22:19Z
House
H
HR
2023-05-05
118
[Congressional Record Volume 169, Number 77 (Friday, May 5, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. HOYLE of Oregon:H.R. 3093.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I of the United States Constitutionand its subsequent amendments, and further clarified andinterpreted by the Supreme Court of the United States.The single subject of this legislation is:To ensure affordable pricing for taxpayer-fundedprescription drugs.[Page H2137]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2023-05-12T15:45:56Z
  - Referred to
2023-05-05T15:05:40Z
- 2023-05-12
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-05-05
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2023-05-05
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-05-05
Introduced in House
IntroReferral
1000
9
Library of Congress
- H001094
Rep. Hoyle, Val T. [D-OR-4]
Val
Hoyle
D
OR
T.
4
N
- D000399
Rep. Doggett, Lloyd [D-TX-37]
LLOYD
DOGGETT
D
TX
37
2023-05-05
True
- C001068
Rep. Cohen, Steve [D-TN-9]
Steve
Cohen
D
TN
9
2023-05-05
True
- D000216
Rep. DeLauro, Rosa L. [D-CT-3]
ROSA
DELAURO
D
CT
3
2023-05-05
True
- G000586
Rep. Garcia, Jesus G. "Chuy" [D-IL-4]
Jesus
Garcia
D
IL
G.
4
2023-05-05
True
- G000551
Rep. Grijalva, Raúl M. [D-AZ-7]
Raúl
Grijalva
D
AZ
M.
7
2023-05-05
True
- J000298
Rep. Jayapal, Pramila [D-WA-7]
Pramila
Jayapal
D
WA
7
2023-05-05
True
- K000009
Rep. Kaptur, Marcy [D-OH-9]
MARCY
KAPTUR
D
OH
9
2023-05-05
True
- K000389
Rep. Khanna, Ro [D-CA-17]
Ro
Khanna
D
CA
17
2023-05-05
True
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2023-05-05
True
- P000597
Rep. Pingree, Chellie [D-ME-1]
Chellie
Pingree
D
ME
1
2023-05-05
True
- P000607
Rep. Pocan, Mark [D-WI-2]
Mark
Pocan
D
WI
2
2023-05-05
True
- S001145
Rep. Schakowsky, Janice D. [D-IL-9]
JANICE
SCHAKOWSKY
D
IL
D.
9
2023-05-05
True
- S001218
Rep. Stansbury, Melanie Ann [D-NM-1]
Melanie
Stansbury
D
NM
Ann
1
2023-05-05
True
- T000487
Rep. Tokuda, Jill N. [D-HI-2]
Jill
Tokuda
D
HI
N.
2
2023-05-05
True
- C001131
Rep. Casar, Greg [D-TX-35]
Greg
Casar
D
TX
35
2023-05-26
False
- T000472
Rep. Takano, Mark [D-CA-39]
Mark
Takano
D
CA
39
2023-06-07
False
- M001223
Rep. Magaziner, Seth [D-RI-2]
Seth
Magaziner
D
RI
2
2023-06-13
False
- T000481
Rep. Tlaib, Rashida [D-MI-12]
Rashida
Tlaib
D
MI
12
2023-08-04
False
Health
- Government information and archives
2023-08-11T14:00:30Z
- Health care costs and insurance
2023-08-11T14:00:30Z
- Prescription drugs
2023-08-11T14:00:30Z
Health
2023-05-19T11:15:21Z
00
2023-05-05
Introduced in House
2024-01-12T15:16:00Z
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
This bill requires companies that receive federal funding for research (or a license of the rights to a patent or regulatory test data) for a biomedical product or service to agree to set reasonable prices for the resulting biomedical product or service.
The Department of Health and Human Services (HHS) must determine a reasonable price based on a formula that ensures the U.S. price for the product or service is not more than the median price for the product or service in Canada and six other reference countries with, based on specified criteria, large economies and high incomes.
Companies entering these agreements also must report to HHS certain financial information related to the biomedical product or service involved.

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
- Display Title
45

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
2024-07-24T15:22:19Z
- Short Title(s) as Introduced
101

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023
2024-05-24T13:40:14Z
Introduced in House
IH
- Official Title as Introduced
6

To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
2024-03-18T20:44:34Z
Introduced in House
IH
- Introduced in House
2023-05-05T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr3093ih/xml/BILLS-118hr3093ih.xml
2023-05-12
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.